Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Aldagen

A company developing regenerative medicines for wound care, inflammation and angiogenesis

Overview Structured Data Issues Contributors Activity

aldagen.com

Is a

Organization

Company

Company attributes

Industry

Biology

Consumer biotechnology

Technology

Biotechnology

Location

Durham, North Carolina

AngelList URL

angel.co/aldagen-cytomedix

Pitchbook URL

pitchbook.com/profiles.../14771-17

CIK Number

1,128,1880

Place of Incorporation

Delaware

Investors

Tullis Health Investors

The Aurora Funds

Intersouth Partners

Harbert Venture Partners

New Markets Venture Partners

DUNS Number

0046439330

IRS Number

562,185,0540

Founded Date

January 1, 2001

Total Funding Amount (USD)

27,400,000

Latest Funding Round Date

April 23, 2008

Latest Funding Type

Series D

CAGE Code

5EJD80

Patents Assigned (Count)

Wellfound ID

aldagen-cytomedix

Country

United States

Other attributes

Acquirer

‌

Cytomedix, Inc.

Company Operating Status

Active

Previous Name

STEMCO BIOMEDICAL INC0

SIC Code

2,8360

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Aldagen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.